Low-Risk Versus High-Risk AML

https://vimeo.com/825225958 How is AML risk determined, and how does it affect treatment options? Dr. Ann-Kathrin Eisfeld defines low-risk and high-risk AML and explains how this classification may predict disease response…

What Is the Purpose of AML Genetic Testing?

https://vimeo.com/820013032 How is genetic testing for AML administered, and what is the purpose? Dr. Sanam Loghavi explains the methods of genetic testing and the function of each method. Dr. Sanam…

The Importance of Acute Myeloid Leukemia Patient Empowerment

https://vimeo.com/808346760 Why is acute myeloid leukemia (AML) patient empowerment vital? How can acute myeloid leukemia (AML) patients become empowered? AML expert Dr. Catherine Lai from Penn Medicine explains how she helps empower…

Becoming an Empowered and [ACT]IVATED AML Patient

Patient Empowerment Network (PEN) is committed to helping educate and empower patients and care partners in the acute myeloid leukemia (AML) community. AML is shown to impact younger patients compared…

Share On:

Facebook
Twitter
LinkedIn